242 studies found for:    Open Studies | United States, Vermont
Show Display Options
Rank Status Study
21 Recruiting Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dacomitinib Plus Blinded Doxycycline or Placebo;   Drug: Dacomitinib Plus Probiotic Plus Topical Alclometasone cream;   Drug: Dacomitinib
22 Recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Procedure: conventional surgery
23 Recruiting Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Conditions: Acute Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Multiple Myeloma
Intervention: Genetic: cytogenetic analysis
24 Recruiting Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIB Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Biological: ipilimumab;   Biological: recombinant interferon alfa-2b;   Other: quality-of-life assessment
25 Recruiting Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: whole breast irradiation
26 Recruiting A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec;   Drug: insulin glargine
27 Recruiting Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: flutamide;   Radiation: radiation therapy
28 Unknown  Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
Condition: Tobacco Use Disorder
Interventions: Behavioral: computer-assisted smoking cessation intervention;   Other: cancer prevention;   Other: educational intervention;   Other: survey administration
29 Recruiting Study Comparing Combination of LGX818 Plus MEK162 and LGX818 Monotherapy Versus Vemurafenib in BRAF Mutant Melanoma
Condition: Melanoma
Interventions: Drug: LGX818;   Drug: LGX818+MEK162;   Drug: vemurafenib
30 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
31 Recruiting Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study
Condition: Chronic Pain
Interventions: Behavioral: Group Cognitive Behavioral Therapy;   Behavioral: Pain Education;   Behavioral: Therapeutic Interactive Voice Response;   Behavioral: NO TIVR
32 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy;   Radiation: Whole-pelvic radiotherapy (WPRT)
33 Recruiting Eisenmenger Quality Enhancement Research Initiative
Condition: Eisenmenger
Intervention: Other: Management
34 Recruiting A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Belimumab plus Early Vaccination;   Biological: Belimumab plus Late Vaccination
35 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
36 Recruiting A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis
Condition: Idiopathic Gastroparesis
Intervention: Drug: Olanzapine
37 Recruiting Safety Study of Adenovirus Vector Engineered to Express hIL-12 (Human Interleukin 12) in Combination With Activator Ligand to Treat Melanoma
Condition: Unresectable Stage III or IV Melanoma
Interventions: Biological: INXN-2001;   Drug: INXN-1001
38 Not yet recruiting Development of a Mobile System for Self-management of Schizophrenia (SOS)
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Behavioral: Mobile Application;   Behavioral: Treatment as Usual
39 Recruiting Open-label Safety Study in Adults With ADHD
Condition: Adult Attention Deficit Hyperactivity Disorder
Intervention: Drug: SEP-225289
40 Recruiting Alisertib (MLN8237) or Investigator&Apos;s Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
Conditions: Relapsed Peripheral T-Cell Lymphoma;   Refractory Peripheral T-Cell Lymphoma
Interventions: Drug: Alisertib;   Drug: Pralatrexate;   Drug: Gemcitabine;   Drug: Romidepsin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years